Effect of long-acting polyethylene glycol recombinant human growth hormone dosages in pediatric practice: A pooled analysis of two phase IV randomized controlled trials
Chin Med J (Engl). 2024 Feb 29.
doi: 10.1097/CM9.0000000000002954.
Online ahead of print.
1 Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
2 Department of Endocrinology, Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China.
3 Department of Paediatrics, First Hospital of Jilin University, Changchun, Jilin 130021, China.
4 Department of Pediatrics, Ningbo Women & Children's Hospital, Ningbo, Zhejiang 315012, China.
5 Department of Pediatric Endocrine Genetics and Metabolism, Chengdu Women's and Children's Center Hospital, Chengdu, Sichuan 610074, China.
6 Department of Pediatrics, Wuhu First People's Hospital, Wuhu, Anhui 241000, China.
7 Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China.
8 Department of Pediatrics, The First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing 400038, China.